Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Choudhury

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
European Urology Focus|July 21, 2017
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder CancerNoura J Choudhury, Kazuma Kiyotani, Kai Lee Yap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB AlterationsNoura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2025
Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular SubtypesCarl M Gay, Taofeek K Owonikoko, Lauren A Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with <i>EGFR</i> Exon 20 InsertionsNoura J Choudhury, Adam J Schoenfeld, Jessica Flynn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.
JCO Precision Oncology|July 12, 2021
Pilot Study of Dacomitinib for Patients With Metastatic <i>EGFR</i>-Mutant Lung Cancers With Disease Progression After Initial Treatment With OsimertinibNoura J Choudhury, Alex Makhnin, Yosef Y Tobi, et al.
JTO Clinical and Research Reports|August 30, 2023
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced <i>ALK</i>- or <i>ROS1</i>-Rearranged NSCLC: A Brief ReportRohit Thummalapalli, Noura J Choudhury, Fiona Ehrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 TumorsJames P Solomon, Soo-Ryum Yang, Noura J Choudhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2025
Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastasesJ A Wilcox, M Y Jeng, S Tischfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung CancerNoura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
European Urology Focus|July 21, 2017
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder CancerNoura J Choudhury, Kazuma Kiyotani, Kai Lee Yap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB AlterationsNoura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2025
Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular SubtypesCarl M Gay, Taofeek K Owonikoko, Lauren A Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with <i>EGFR</i> Exon 20 InsertionsNoura J Choudhury, Adam J Schoenfeld, Jessica Flynn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.
JCO Precision Oncology|July 12, 2021
Pilot Study of Dacomitinib for Patients With Metastatic <i>EGFR</i>-Mutant Lung Cancers With Disease Progression After Initial Treatment With OsimertinibNoura J Choudhury, Alex Makhnin, Yosef Y Tobi, et al.
JTO Clinical and Research Reports|August 30, 2023
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced <i>ALK</i>- or <i>ROS1</i>-Rearranged NSCLC: A Brief ReportRohit Thummalapalli, Noura J Choudhury, Fiona Ehrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 TumorsJames P Solomon, Soo-Ryum Yang, Noura J Choudhury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2025
Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastasesJ A Wilcox, M Y Jeng, S Tischfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung CancerNoura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
Pageof 6